| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 74 | 2023 |
| Free copper in serum: An analytical challenge and its possible applications S Catalani, M Paganelli, ME Gilberti, L Rozzini, F Lanfranchi, A Padovani, ... Journal of Trace Elements in Medicine and Biology 45, 176-180, 2018 | 61 | 2018 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet, 2024 | 28 | 2024 |
| Serum non-ceruloplasmin non-albumin copper elevation in mild cognitive impairment and dementia due to Alzheimer’s disease: a case control study L Rozzini, F Lanfranchi, A Pilotto, S Catalani, ME Gilberti, M Paganelli, ... Journal of Alzheimer's Disease 61 (3), 907-912, 2018 | 23 | 2018 |
| The role of the immune metabolic prognostic index in patients with non-small cell lung cancer (NSCLC) in radiological progression during treatment with nivolumab M Bauckneht, C Genova, G Rossi, E Rijavec, MG Dal Bello, G Ferrarazzo, ... Cancers 13 (13), 3117, 2021 | 17 | 2021 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 14 | 2024 |
| Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson’s disease (PD) and dementia with Lewy bodies (DLB) F Lanfranchi, D Arnaldi, A Miceli, P Mattioli, F D’Amico, S Raffa, ... European Journal of Nuclear Medicine and Molecular Imaging 50 (4), 1090-1102, 2023 | 12 | 2023 |
| Metformin and cancer glucose metabolism: At the bench or at the bedside? C Marini, V Cossu, M Bauckneht, F Lanfranchi, S Raffa, AM Orengo, ... Biomolecules 11 (8), 1231, 2021 | 12 | 2021 |
| Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap S Morbelli, S Chiola, MI Donegani, D Arnaldi, M Pardini, R Mancini, ... European Journal of Nuclear Medicine and Molecular Imaging, 1-12, 2022 | 11 | 2022 |
| Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223 M Bauckneht, R Lai, F D’Amico, A Miceli, MI Donegani, C Campi, ... Annals of Nuclear Medicine 36 (4), 373-383, 2022 | 8 | 2022 |
| ITA-IMMUNO-PET: the role of [18F] FDG PET/CT for assessing response to immunotherapy in patients with some solid tumors L Evangelista, A Bianchi, A Annovazzi, R Sciuto, S Di Traglia, ... Cancers 15 (3), 878, 2023 | 6 | 2023 |
| Clinical and diagnostic findings of acute macular neuroretinopathy and paracentral acute middle maculopathy in the COVID-19 Era E Premi, R Acampora, D Salmi, I Ilie, N Pagnoncelli, F Germano, ... Ophthalmologica 246 (3-4), 181-191, 2023 | 4 | 2023 |
| Exploring the brain metabolic correlates of process-specific CSF biomarkers in patients with MCI due to Alzheimer's disease: preliminary data F Massa, S Halbgebauer, L Barba, P Oeckl, NG de San José, ... Neurobiology of aging 117, 212-221, 2022 | 4 | 2022 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 3 | 2024 |
| Frontiers of COVID-19 S Adibi, P Griffin, M Sanicas, M Rashidi, F Lanfranchi Spatial Epidemiology of COVID-19 Pandemic: Disease Risk, Prognosis, and …, 2022 | 3 | 2022 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The Lancet, 2024 | 2 | 2024 |
| Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A … A Bianchi, ML De Rimini, R Sciuto, A Annovazzi, S Di Traglia, ... Cancer Biotherapy & Radiopharmaceuticals 38 (4), 256-267, 2023 | 2 | 2023 |
| Oligometastatic Prostate Cancer Treated with Metastasis-Directed Therapy Guided by Positron Emission Tomography: Does the Tracer Matter? F Lanfranchi, L Belgioia, M Marcenaro, E Zanardi, G Timon, M Riondato, ... Cancers 15 (1), 323, 2023 | 2 | 2023 |
| Mitochondrial Generated Redox Stress Differently Affects the Endoplasmic Reticulum of Circulating Lymphocytes and Monocytes in Treatment-Naïve Hodgkin’s Lymphoma C Marini, V Cossu, M Bauckneht, S Carta, F Lanfranchi, F D’Amico, ... Antioxidants 11 (4), 762, 2022 | 2 | 2022 |
| Spleen perfusion as an index of gender impact on sympathetic nervous system response to exercise F Lanfranchi, F D'Amico, S Raffa, M Pennone, MI Donegani, A Miceli, ... Frontiers in Physiology 12, 780713, 2021 | 2 | 2021 |
